Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Carbon Design Innovations, Inc. Introduces Carbon Nanotube Probe Technology for Atomic Force Microscopy, CNT-Probes Deliver New Level of AFM Imaging Performance

High-aspect Ratio AFM CNT Probe from Carbon Design Innovations
High-aspect Ratio AFM CNT Probe from Carbon Design Innovations

Abstract:
Carbon Design Innovations, Inc. (C|D|I) today announced the availability of two new atomic force microscope (AFM) probes types with carbon nanotube (CNT) tips. The CCHAR (carbon core high-aspect ratio) and CCHR (carbon core high-resolution) CNT probes offer quantum improvements for AFM imaging, substantially improving results, reducing overall cost of operation and opening new avenues for research.

Carbon Design Innovations, Inc. Introduces Carbon Nanotube Probe Technology for Atomic Force Microscopy, CNT-Probes Deliver New Level of AFM Imaging Performance

Burlingame, CA | Posted on June 16th, 2009

Carbon Design Innovations, Inc.(C|D|I) today announced the availability of two new atomic force microscope (AFM) probes types with carbon nanotube (CNT) tips. The CCHAR (carbon core high-aspect ratio) and CCHR (carbon core high-resolution) CNT probes offer quantum improvements for AFM imaging, substantially improving results, reducing overall cost of operation and opening new avenues for research.

"The carbon nanotube AFM probes from C|D|I reveal the most accurate surface morphology, especially for cellular samples such as rat basophilic lymphocytes cells," states Dr. G. Y. Liu, University of California, Davis. "All observations reflect upon the superior geometry of these CCHAR probes, which exhibit little convolution in AFM imaging. We certainly hope to see these advantages among other biological specimens such as, proteins, tissues and biopolymeric materials."

"AFM researchers understand that the next leap in AFM productivity will be based on improved probe technology," said Vance Nau, CEO, Carbon Design Innovations. "They have been looking for reliable CNT probes for many years, however, the inability to consistently manufacture CNT probes that live up to their promise has limited widespread adoption, frustrating users and manufacturers alike."

C|D|I has a patent pending process for the deterministic manufacture of carbon nanotube (CNT) devices. Based on this breakthrough process, the company is able to produce CNT AFM probes that are perfectly straight and precisely aligned, allowing them to be set at desired angles to the surface. The CNT is at the core of the probe structure and the CNT is securely anchored providing for robust and stable imaging with previously unseen levels of performance. C|D|I's CNT probes are more stable and have longer imaging lifetimes than other probe types. In addition, the ability to reinforce longer probes and control taper angle provides users with deep-trench scanning ability not currently available. As a result, C|D|I probes offer customers greater imaging flexibility, performance and reproducibility that will enable them to make significant advances in AFM research. The new CNT AFM probes from C|D|I are compatible with all major AFM systems, giving users an easy path for improving AFM performance without making a substantial investment in new instrumentation.

The CCHAR probe offers high-aspect ratio imaging capability and is designed for materials science, metrology and life science applications. It offers stability and durability in a high-aspect ratio probe designed for difficult to resolve scanning operations such as deep-trench imaging. The nominal CNT total probe length is 1u with the exposed CNT length being 500nm. The CCHAR can be mounted onto any AFM Cantilever.

The CCHR probe family provides high-resolution for material science and life science applications. It offers the durability, stability and high resolution capabilities of a multi-wall CNT tip. The nominal total CNT length is 500 nm, with the exposed CNT tip less than 200 nm. It can be mounted onto any AFM cantilever.

C|D|I probes are now available for order and will begin shipping in the third quarter of 2009.

The Company also today announced that they have secured angel funding from a group of private investors.

####

About Carbon Design Innovations, Inc.
Carbon Design Innovations develops and manufactures carbon nanotube devices based on a patented, deterministic methodology. The company's initial focus is on manufacturing AFM probes.

The company was founded by AFM and CNT industry veteran and company president, Ramsey M. Stevens in January, 2008. Vance Nau, Ph.D. joined the company as CEO in July 2008. Nau has over 25 years experience in management at scientific instrumentation companies and recently led AFM manufacturer Molecular Imaging for five years until its successful acquisition by Agilent Technologies.

For more information, please click here

Contacts:
Phone: +1.650.697.7070
FAX: +1.650.648.0581

Copyright © PRWeb

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Drilling speed increased by 20% yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chirality in 'real-time' January 14th, 2019

New materials could help improve the performance of perovskite solar cells January 11th, 2019

Media invited to open meeting on the future of quantum technology held at RIT Jan. 23-25: Leaders from NASA, NSF, NIST and Sandia National Laboratory to attend January 11th, 2019

Investments/IPO's/Splits

Nanometrics to Participate in the 21st Annual Needham Growth Conference January 7th, 2019

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) December 18th, 2018

180 Degree Capital Corp.s Portfolio Company, TheStreet, Inc., Agrees to Sell Its Institutional Business Units to Euromoney Institutional Investor PLC for $87.3 Million December 6th, 2018

These small caps are tapping a graphene market that has more than doubled in a year December 1st, 2018

Nanotubes/Buckyballs/Fullerenes/Nanorods

Drilling speed increased by 20% yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chemical synthesis of nanotubes: Nanometer-sized tubes made from simple benzene molecules January 11th, 2019

'Smart skin' simplifies spotting strain in structures: Rice U. invention can use fluorescing carbon nanotubes to reveal stress in aircraft, structures November 15th, 2018

Ultrasensitive toxic gas detector October 31st, 2018

Nanomedicine

Chirality in 'real-time' January 14th, 2019

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7th, 2019

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia January 7th, 2019

Announcements

Drilling speed increased by 20% yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chirality in 'real-time' January 14th, 2019

Spintronics 'miracle material' put to the test: Physicists build devices using mineral perovskite January 11th, 2019

Cartilage could be key to safe 'structural batteries' January 11th, 2019

Tools

Drilling speed increased by 20% yet another upgrade in the oil & gas sector made possible by graphene nanotubes January 15th, 2019

Chirality in 'real-time' January 14th, 2019

DNA design that anyone can do: Computer program can translate a free-form 2-D drawing into a DNA structure January 4th, 2019

Using sound to independently levitate a range of objects is achieved for the first time December 28th, 2018

Nanobiotechnology

Cartilage could be key to safe 'structural batteries' January 11th, 2019

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7th, 2019

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia January 7th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project